S, T., V, S., NY, M., MF, N., DS, G., ER, G., . . . SR, V. (2022). A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer. Cell reports, 38(8), 110417. https://doi.org/10.1016/j.celrep.2022.110417
Chicago Style (17th ed.) CitationS, Tang, et al. "A Genome-scale CRISPR Screen Reveals PRMT1 as a Critical Regulator of Androgen Receptor Signaling in Prostate Cancer." Cell Reports 38, no. 8 (2022): 110417. https://doi.org/10.1016/j.celrep.2022.110417.
MLA (9th ed.) CitationS, Tang, et al. "A Genome-scale CRISPR Screen Reveals PRMT1 as a Critical Regulator of Androgen Receptor Signaling in Prostate Cancer." Cell Reports, vol. 38, no. 8, 2022, p. 110417, https://doi.org/10.1016/j.celrep.2022.110417.